Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06280105
What this trial is testing

A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

Who this might be right for
Hepatocellular Carcinoma
Meng Chao Hepatobiliary Hospital of Fujian Medical University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Testing effectiveness (Phase 2)UnknownNCT03344614
What this trial is testing

Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03510416
What this trial is testing

Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
Shanghai Zhongshan Hospital 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06632522
What this trial is testing

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Who this might be right for
Liver Cancer
Beijing Tsinghua Chang Gung Hospital 46
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Early research (Phase 1)UnknownNCT04665362
What this trial is testing

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Who this might be right for
Advanced/Metastatic Hepatocellular Carcinoma
Liang Peng 10
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Not applicableUnknownNCT04174339
What this trial is testing

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Adenocarcinoma
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Large-scale testing (Phase 3)UnknownNCT03651219
What this trial is testing

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Beijing Chest Hospital 90
Testing effectiveness (Phase 2)UnknownNCT05342389
What this trial is testing

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 68
Testing effectiveness (Phase 2)UnknownNCT03868852
What this trial is testing

Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children

Who this might be right for
Childhood Rhabdomyosarcoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 48
Testing effectiveness (Phase 2)UnknownNCT03201146
What this trial is testing

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Who this might be right for
Lung CancerNon Small Cell Lung CancerCombination Chemotherapy+1 more
West China Hospital 48
Post-approval studies (Phase 4)UnknownNCT03631862
What this trial is testing

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University 100
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Large-scale testing (Phase 3)Not Yet RecruitingNCT06188455
What this trial is testing

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
The First Affiliated Hospital of Xiamen University 37
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Testing effectiveness (Phase 2)UnknownNCT04792515
What this trial is testing

Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Next Page